MDR & IVDR CE Marking Crisis? I3CGLOBAL Provides the Compliance Edge Manufacturers Need

CALIFORNIA CITY, Calif. - April 30, 2026 - PRLog -- In response to the increasing complexity of European medical device regulations, I3CGLOBAL, a globally recognised regulatory consulting firm, is strengthening its position as a trusted partner for MDR and IVDR CE marking (https://www.i3cglobal.com/medical-device-ce-marking/) services. With a strong track record of successful submissions and approvals, the company supports manufacturers in navigating the stringent requirements of the European Union with confidence and efficiency.

The transition from MDD to MDR and IVDD to IVDR has significantly raised expectations for clinical evidence, technical documentation, and post-market surveillance. Many manufacturers face delays, non-conformities, and costly rework due to evolving regulatory expectations and limited notified body capacity. I3CGLOBAL addresses these challenges through a structured, end-to-end consulting approach that ensures compliance while accelerating time to market.

Comprehensive MDR & IVDR CE Marking Support

I3CGLOBAL offers a full spectrum of services tailored to medical device and IVD manufacturers, including:

• Regulatory strategy and pathway identification
• Clinical Evaluation Reports (CER) and Performance Evaluation Reports (PER)
• Technical Documentation preparation (Annex II & III)
• Risk Management and Biological Evaluation support
• Post-Market Clinical Follow-up (PMCF) and PMS systems
• Notified Body coordination and submission support

With a team of experienced regulatory professionals, biomedical experts, and clinical specialists, the company ensures that every submission meets the latest MDR (EU 2017/745) and IVDR (EU 2017/746) requirements.

Addressing Medical Device and IVD Manufacturers' Challenges

With notified bodies facing capacity constraints and regulatory scrutiny increasing, manufacturers need more than just documentation support; they need strategic guidance. I3CGLOBAL differentiates itself by offering proactive regulatory planning, gap assessments, and continuous support throughout the product lifecycle.

"Our focus is not just compliance but successful approvals," said a spokesperson from I3CGLOBAL. "We work closely with manufacturers to ensure their devices meet all regulatory expectations from the first submission, minimising delays and maximising market access opportunities."

About I3CGLOBAL

Since its inception, I3CGLOBAL has successfully supported over 1500 CE marking Certifications (https://www.i3cglobal.com/medical-device-ce-certification/) and numerous FDA 510(k) clearances across a wide range of medical devices and in vitro diagnostics. The firm works with startups, SMEs, and multinational manufacturers, providing customised solutions that align with both regulatory requirements and business goals.

I3CGLOBAL is a leading regulatory consulting firm specialising in medical devices and in vitro diagnostics. The company provides end-to-end support for MDR and IVDR CE marking, FDA 510(k) submissions, WHO prequalification, and global regulatory compliance. With decades of combined expertise, I3CGLOBAL has become a preferred partner for manufacturers seeking reliable, efficient, and high-quality regulatory solutions.